Analyzing the healthcare expenditure on pharmaceuticals and medical non-durable goods in Italy from 2013 to 2023, we observe fluctuations with some stable trends. The expenditure in 2023 stood at 17.91 units of total current health expenditure, a slight increase from 2022. Year-on-year growth varied notably, with significant increases in 2015 and 2019 but also notable declines in 2020 and 2021. The Compound Annual Growth Rate (CAGR) over the past five years was modest at 0.011%. Looking ahead to 2028, the forecast predicts minimal growth, reflected by a 5-year CAGR of 0.06%.
Future trends to monitor:
- Potential impacts of new healthcare policies on pharmaceutical expenditure.
- Technological advancements in medical treatments influencing cost structures.
- Economic factors and their implications for healthcare budgets.
